rs878924060
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_001164507.2(NEB):c.11077-4G>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.10 ( 0 hom., cov: 21)
Exomes 𝑓: 0.032 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
NEB
NM_001164507.2 splice_region, intron
NM_001164507.2 splice_region, intron
Scores
2
Splicing: ADA: 0.000008029
2
Clinical Significance
Conservation
PhyloP100: -1.17
Publications
1 publications found
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
- nemaline myopathy 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
- childhood-onset nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intermediate nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- typical nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- lethal multiple pterygium syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- severe congenital nemaline myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-151617472-C-A is Benign according to our data. Variant chr2-151617472-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 283780.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NEB | NM_001164507.2 | c.11077-4G>T | splice_region_variant, intron_variant | Intron 74 of 181 | ENST00000427231.7 | NP_001157979.2 | ||
| NEB | NM_001164508.2 | c.11077-4G>T | splice_region_variant, intron_variant | Intron 74 of 181 | ENST00000397345.8 | NP_001157980.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NEB | ENST00000397345.8 | c.11077-4G>T | splice_region_variant, intron_variant | Intron 74 of 181 | 5 | NM_001164508.2 | ENSP00000380505.3 | |||
| NEB | ENST00000427231.7 | c.11077-4G>T | splice_region_variant, intron_variant | Intron 74 of 181 | 5 | NM_001164507.2 | ENSP00000416578.2 | |||
| NEB | ENST00000486320.1 | n.14G>T | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 | |||||
| NEB | ENST00000409198.5 | c.10348-4G>T | splice_region_variant, intron_variant | Intron 71 of 149 | 5 | ENSP00000386259.1 |
Frequencies
GnomAD3 genomes AF: 0.100 AC: 8919AN: 89130Hom.: 0 Cov.: 21 show subpopulations
GnomAD3 genomes
AF:
AC:
8919
AN:
89130
Hom.:
Cov.:
21
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.113 AC: 4057AN: 35788 AF XY: 0.117 show subpopulations
GnomAD2 exomes
AF:
AC:
4057
AN:
35788
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0321 AC: 23078AN: 719696Hom.: 0 Cov.: 13 AF XY: 0.0346 AC XY: 12460AN XY: 360516 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
23078
AN:
719696
Hom.:
Cov.:
13
AF XY:
AC XY:
12460
AN XY:
360516
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
632
AN:
17970
American (AMR)
AF:
AC:
887
AN:
15856
Ashkenazi Jewish (ASJ)
AF:
AC:
625
AN:
13968
East Asian (EAS)
AF:
AC:
594
AN:
26120
South Asian (SAS)
AF:
AC:
2737
AN:
36566
European-Finnish (FIN)
AF:
AC:
687
AN:
24618
Middle Eastern (MID)
AF:
AC:
95
AN:
2384
European-Non Finnish (NFE)
AF:
AC:
15834
AN:
549514
Other (OTH)
AF:
AC:
987
AN:
32700
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.344
Heterozygous variant carriers
0
1344
2688
4031
5375
6719
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.100 AC: 8919AN: 89094Hom.: 0 Cov.: 21 AF XY: 0.0933 AC XY: 4026AN XY: 43134 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
8919
AN:
89094
Hom.:
Cov.:
21
AF XY:
AC XY:
4026
AN XY:
43134
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
2762
AN:
19442
American (AMR)
AF:
AC:
596
AN:
10494
Ashkenazi Jewish (ASJ)
AF:
AC:
265
AN:
2070
East Asian (EAS)
AF:
AC:
151
AN:
3464
South Asian (SAS)
AF:
AC:
244
AN:
2510
European-Finnish (FIN)
AF:
AC:
213
AN:
5304
Middle Eastern (MID)
AF:
AC:
7
AN:
168
European-Non Finnish (NFE)
AF:
AC:
4510
AN:
43798
Other (OTH)
AF:
AC:
111
AN:
1258
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.279
Heterozygous variant carriers
0
769
1538
2306
3075
3844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Oct 13, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Nemaline myopathy 2 Benign:2
Aug 29, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Apr 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.